Renal Cell Carcinoma
- 7 July 2004
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 292 (1) , 97-100
- https://doi.org/10.1001/jama.292.1.97
Abstract
Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancy and 90% to 95% of neoplasms arising from the kidney. It is the sixth leading causKeywords
This publication has 16 references indexed in Scilit:
- Immunological Effects of Granulocyte-Macrophage Colony-Stimulating Factor and Autologous Tumor Vaccine in Patients With Renal Cell CarcinomaJournal of Urology, 2004
- Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trialThe Lancet, 2004
- The Genetic Basis of Cancer of the KidneyJournal of Urology, 2003
- Long-term outcome of laparoscopic radical nephrectomy for pathologic T1 renal cell carcinomaUrology, 2003
- A Pilot Trial of Tumor Lysate-Loaded Dendritic Cells for the Treatment of Metastatic Renal Cell CarcinomaJournal of Immunotherapy, 2003
- Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell CancerNew England Journal of Medicine, 2001
- Rising Incidence of Renal Cell Cancer in the United StatesJAMA, 1999
- Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.Proceedings of the National Academy of Sciences, 1996
- A Phase I Randomized Study of Subcutaneous Adjuvant IL-2 in Combination with an Autologous Tumor Vaccine in Patients with Advanced Renal Cell CarcinomaJournal of Immunotherapy, 1996
- The Role of Adjunctive Nephrectomy in Patients with Metastatic Renal Cell CarcinomaJournal of Urology, 1977